Gout Management—Need for Greater Attentiveness to Broader Treatment

Treating patients at risk for or diagnosed with type 2 diabetes should be closely monitored for gout-related disease, with treat-to-target therapy initiated early with ongoing monitoring, informed by new consensus statement, and clinical guidelines pending from the American College of Rheumatology.